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The Cellular Expression of Antiangiogenic Factors in
Fetal Primate Macula
Peter Kozulin,1 Riccardo Natoli,1 Keely M. Bumsted O’Brien,1 Michele C. Madigan,2,3
and Jan M. Provis1,4
PURPOSE. To characterize the cellular expression patterns of
antiangiogenic factors differentially regulated in the fetal hu-
man macula.
METHODS. RNA was extracted from macular, nasal, and sur-
round biopsies of three human fetal retinas at midgestation.
Relative levels of expression of pigment epithelium–derived
factor (PEDF), brain natriuretic peptide (BNP), collagen type
IV2 (COL4A2), and natriuretic peptide receptors A and C
(NPRA and NPRC) were determined with quantitative PCR.
Cellular expression of PEDF and BNP was investigated by in
situ hybridization on retinal sections from monkeys aged be-
tween fetal day 55 and 11 years. BNP, COL4A2, and NPRA
proteins were localized by immunohistochemistry. Labeling
was imaged and quantified by confocal microscopy and optical
densitometry.
RESULTS. Quantitative PCR confirmed higher levels of PEDF and
BNP and lower levels of COL4A2 in the macula at midgestation.
PEDF mRNA was detected in ganglion cells (GCs) and the
pigment epithelium (RPE). BNP mRNA was detected in GCs
and macroglia, although BNP immunoreactivity (IR) was pre-
dominantly perivascular. COL4A2-IR was detected in large
blood vessels and NPRA-IR on the retinal vascular endothelium,
GC axons in fetal retinas, and cone axons at all ages. Optical
densitometry showed a graded expression of PEDF and BNP at
all ages, with highest levels of expression in GCs in the devel-
oping fovea.
CONCLUSIONS. Because the retinal vessels initially form in the GC
layer, it is likely that PEDF has a key role in defining and main-
taining the foveal avascular area. The precise role of BNP is
unclear, but it may include both antiangiogenic and natriuretic
functions. (Invest Ophthalmol Vis Sci. 2010;51:4298–4306) DOI:
10.1167/iovs.09-4905
The retinal vasculature in primates is characterized by anarcuate pattern of blood vessel growth around the macula,
a lack of large-diameter vessels in the macula, and an absence
of retinal vessels from the foveal region.1–5 Finite element
analysis modeling suggests that definition of the foveal avascu-
lar area is a prerequisite for development of the foveal depres-
sion,6,7 and several clinical studies confirm that the foveal
depression does not form in the absence of a foveal avascular
area. Absence of a foveal depression is often associated with
vision loss,8–13 but may also occur as part of the normal
spectrum.14 In mature eyes, neovascularization of the macula
occurs in age-related macular degeneration and high myopia
and is the cause of sudden vision loss. We have recently
identified three antiangiogenic factors among the more than
2000 genes differentially expressed in the macula15,16: natri-
uretic peptide precursor B, also known as brain natriuretic
peptide (BNP), pigment epithelium–derived factor (PEDF),
and collagen type IV2 (COL4A2). As part of the validation of
our microarray study, we confirmed higher levels of PEDF
expression in the fetal macula by quantitative PCR (QRT-PCR)
and, by in situ hybridization (ISH), we showed PEDF mRNA
expression by ganglion cells (GCs) in fetal macaque retinas.
We report a longitudinal study of the expression patterns
and immunoreactivity of these three factors. First, we report
QRT-PCR findings for collagen type IV2, BNP, and its recep-
tors, and PEDF, to verify the data from the microarray. Second,
we show for the first time that PEDF mRNA is highly expressed
by foveal GCs throughout fetal life and in the postnatal period
and discuss the effect of this expression on retinal vascular
development in the macula. Third, we show that BNP mRNA,
like PEDF, is expressed by GCs in the macula and report
quantitative findings that show for the first time that BNP is
differentially expressed in the macula into adulthood in ma-
caque retinas. We also report the immunolocalization of BNP
and its receptor NPRA in fetal and adult macaque retinas.
Finally, in view of these findings and a recent report on ex-
pression patterns of the guidance factor EphA6 and its recep-
tors,17 we provide an update on development of the primate
retinal vasculature, including the likely roles of PEDF and
EphA6.
Understanding the genes that normally regulate vascular
patterning in the macula and around the fovea is central to
understanding the disease processes that lead to pathologic
neovascularization and can contribute to the development of
therapeutic strategies to inhibit pathogenic blood vessel
growth in the macula.
METHODS
Specimens
Human Retinas. Four human retinas—three at 19 weeks’ ges-
tation (WG) and one at 21 WG—were obtained with maternal consent
and ethical approval from the Human Ethics Committees of The Uni-
versity of Sydney and The Australian National University, in accordance
with the tenets of the Declaration of Helsinki. Ultrasound and post
mortem measurements of foot length were used to determine gesta-
tional age. The 19 WG retinas were used for RNA extraction, whereas
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the 21 WG retina was fixed in 2% paraformaldehyde and prepared as a
wholemount.
Macaque Retinas. We used histologic sections from 10 ma-
caque retinas at fetal day (Fd) 55, 80, 110, 120, 145, 150, and 164;
postnatal (P) d5, P 3 month (m), and 11 years old (yo). Animals were
obtained by Anita E. Hendrickson from the breeding colony of the
Primate Center at Bogor Agricultural University, Indonesia, using pro-
tocols approved by the University of Washington (Seattle) Animal Care
Committee and in compliance with the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research. Fetuses were delivered by
aseptic cesarean section and euthanatized by intraperitoneal overdose
of barbiturate, after which the eyes were enucleated and processed as
described previously.18 Only sections passing through the optic disc
and macular region were used for quantitative analysis in this study.
RNA Extraction and PCR
RNA was extracted from biopsies of human retinas at 19 WG, 90 to 120
minutes after death, as described previously.15 Biopsies were obtained
in the macular region (macula) and an analogous region nasal to the
optic disc (nasal), using a 5-mm trephine. The remaining retina con-
stituted the third sample region (surround). RNA was extracted as
described previously.15,17 First-strand cDNA synthesis was performed
in a 20-L reaction mixture with 1 g RNA, 500 ng oligo (dT)18
primer, and 200 U reverse transcriptase (SuperScript III; Invitrogen,
Carlsbad, CA). Human probes (TaqMan; Applied Biosystems, Carlsbad,
CA) (Table 1) were used for QRT-PCR (Rotor-Gene RG-3000; Corbett
Research, Sydney, NSW, Australia) and an FAM 510-nm fluorescence
detection channel. The fluorescent signal for each gene was normalized
against the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) refer-
ence gene. QRT-PCR was performed in triplicate on the three biopsies
from each of three 19-WG retinas (total of nine reactions per gene). The
Pfaffl19 method of relative quantification was used to analyze gene ampli-
fication, with the specificity of amplification determined by gel electro-
phoresis (1% agarose gel).
In Situ Hybridization
BNP, PEDF, and natriuretic peptide receptor C (NPRC) were cloned
from PCR products by using total RNA from human fetal retinas, as
described previously.15 The primers were designed within the coding
domain sequence of the NCBI Entrez Gene RefSeq database (http://
www.ncbi.nlm.nih.gov/locuslink/refseq/ provided in the public do-
main by the National Center for Biotechnology Information, Bethesda,
MD). The primers used were (5 to 3): BNP, forward GATCCCCAGA-
CAGCACCTT, reverse, taatgccgcctcagcact (corresponding to nucleotides
106-506 of RefSeq NM_002521); NPRC, forward, AGCATACTCGTCCCTC-
CAGA, reverse, GGTTCGCCTCTCAATGGTTA (nucleotides 1160-1763 of
NM_000908); PEDF, forward, TCATTCACCGGGCTCTCTAC, reverse,
AGGGGCAGGAAGAAGATGAT (nucleotides 465-996 of NM_002615).
The genes were cloned with a DNA vector system (pGEM-T; Pro-
mega, Madison, WI) and JM109 competent cells (A3600; Promega). A
DIG RNA-labeling kit (SP6/T7, 1175025; Roche, Basel, Switzerland)
was used to transcribe linearized plasmid and generate DIG-labeled
antisense and sense probes. Paraffin-embedded sections of fetal ma-
caque retina were processed as described previously.17 The BNP,
NPRC, and PEDF riboprobes were hybridized overnight at 55°C, 55°C,
and 58°C, respectively, and washed in saline sodium citrate (pH 7.4) at
62°C, 62°C, and 58°C, respectively. After hybridization, mRNA labeling
was visualized with an HNPP fluorescent detection set (1758888;
Roche), as described previously.17 Sections hybridized to show BNP
expression were counterimmunolabeled (as described elsewhere18)
with a mixture of antibodies to glial fibrillary acidic protein (GFAP) and
vimentin (Table 2), to visualize the retinal macroglia. Sections were
scanned immediately or stored at 20°C and scanned within 24 hours
after completion of the Fast Red incubation.
Immunolabeling
A list of antibodies and their dilutions is shown in Table 2. Immuno-
labeling of sections was performed by using standard protocols (see
TABLE 1. Human Genetic Probes
Entrez Gene ID* Gene Probe ID† Amplicon Length
4879 BNP Hs00173590_ml 82
1284 COL4A2 Hs01098873_ml 65
2597 GAPDH Hs99999905_ml 122
4881 NPRA Hs00181445_ml 75
4883 NPRC Hs00168558_ml 74
5176 PEDF Hs01106937_ml 84
BNP, brain natriuretic peptide; COL4A2, collagen type IV2;
GAPDH, glyceraldehyde-3- phosphate dehydrogenase; NPRA, natri-
uretic peptide receptor A; NPRC, natriuretic peptide receptor C; PEDF,
pigment epithelium–derived factor.
* Entrez Gene, http://www.ncbi.nlm.nih.gov/gene/ National Insti-
tutes of Health, Bethesda, MD.
† Taqman; ABI, Carlsbad, CA.
TABLE 2. Antibodies Used
Antibody Dilution Manufacturer
Primary antibodies
Human CD31 (mouse, mono) 1:50 DakoCytomation, Glostrup, Denmark
Cellular retinaldehyde binding protein (CRALBP) (mouse, poly)* 1:1000 Donated by John Saari, University of Washington, Seattle
Human collagen type IV2 (mouse, mono) 1:100 Millipore, Billerica, MA
Glial fibrillary acidic protein (GFAP) (mouse, mono)* 1:1000 Thermo Scientific, Waltham, MA
Human brain natriuretic peptide (BNP)-32 (rabbit, poly) 1:50 Bachem, Torrance, CA
Natriuretic peptide receptor A (NPRA) (rabbit, poly)* 1:50† Abcam, Cambridge, UK
Human natriuretic peptide receptor C (NPRC) (rabbit, poly) 1:50† Abcam
Rhodopsin (mouse, mono)* 1:100 Millipore
Vimentin (mouse, mono)* 1:250 DakoCytomation
Control antibody
Normal rabbit IgG 1:200† R&D Systems, Minneapolis, MN
Secondary antibodies
Biotinylated goat anti-rabbit 1:200 Invitrogen, Carlsbad, CA
Biotinylated goat anti-mouse 1:200 Invitrogen
Visualization
Conjugated goat anti-mouse Alexa 594 1:1000 Invitrogen
Streptavidin Alexa 488 1:1000 Invitrogen
mono, monoclonal; poly, polyclonal.
* Cross-reactive to human and several other species.
† NRPA/NPRC antibody stock concentration was 0.25 mg/mL, and normal rabbit IgG stock concentration was 1 mg/mL.
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also Kozulin et al.17). Sections were incubated in antigen recovery
solution (Revealit-Ag, AR1002; ImmunoSolution, Newcastle, Australia)
for 20 minutes at 85°C to unmask antigens, and then blocked in 10%
serum (diluted in PBS) for 1 hour at room temperature, before over-
night incubation at 4°C in a mixture of primary antibodies. Binding of
one primary antibody was visualized by incubation in a biotinylated
secondary antibody for 1.5 hours, followed by incubation in streptavi-
din Alexa 488. Binding of the second primary antibody was visualized
with Alexa 594 conjugated to the appropriate secondary antibody (4
hours incubation at 4°C). All antibodies were diluted in 0.01% Triton
PBS.
For the wholemount, the retina was dissected from the RPE and
choroid and rinsed in 10% serum in PBS for 1 hour at room tempera-
ture before incubation in anti-human collagen type IV2 diluted in
0.01% Triton PBS, for 3 days at 4°C. After a thorough rinsing in PBS, the
retinas were incubated in biotinylated secondary antibody and then
streptavidin Alexa 488, each overnight. The retinas were flatmounted
and viewed by confocal microscopy.
Imaging
Imaging was performed with a confocal microscope system (LSM 5,
PASCAL ver. 4.0 software; Carl Zeiss Meditec, Inc., Jena, Germany) and
an HeNe 543 nm and Argon 488 nm scanning lasers (LASOS, Jena,
Germany). Scans of ISH were taken with a 40 objective over a field
size of 225  225 m with a 1024  1024-pixel resolution in 8-bit
format (pixel intensity range, 0–255). Optical sections of BNP ISH
were taken over varying thickness according to the age of tissue; four
sections of Fd 55 tissue (2.4 m Z-stack), five sections of Fd 70 to P 3m
tissue (Z-stack range, 3.2–4.0 m) and six sections of 11 yo tissue
(4.4 m Z-stack). Optical sections of PEDF ISH were taken over a
constant Z-stack size of 3.0 m (seven sections) except for the speci-
men at Fd 164 (450  450-m field size, Z-stack size of 5.1 m, seven
sections).
Laser transmission and scan settings were constant in all scans of a
single specimen, to allow comparison of labeling intensity between the
different regions. Raw images were imported into ImageJ (version
1.41, developed by Wayne Rasband, National Institutes of Health,
Bethesda, MD; available at http://rsb.info.nih.gov/ij/index.html) and
compiled by using the Z projection tool (average intensity). For optical
densitometry of the Fast Red reaction product, the 594-nm signal
channel was isolated, and the images converted to 8-bit grayscale
format before compilation in ImageJ. The compiled, grayscale images
were inverted (Invert tool, Photoshop CS3, ver. 10.0.1; Adobe Systems
Inc., San Jose, CA) so that the color reaction appears dark on a bright
background, for better rendition in print. Any adjustments to contrast
and brightness were made with identical settings across all images
from any one specimen, so that the printed images represent real
differences in color reaction intensity.
Optical Densitometry Analysis
For quantitative analysis of hybridized sections, six retinal regions were
scanned18: (1) nasal to the optic disc (nasal), such that the nasal and
mid scans are equidistant from the optic disc; (2) immediately tempo-
ral to the optic disc (TOD); (3) midway between the macula and optic
disc (mid); (4) on the nasal foveal rim (rim); (5) the central fovea
(fovea); and (6) temporal to the fovea (temporal), such that the (3) mid
and (6) temporal samples are equidistant from the fovea. We used
ImageJ and optical densitometry to quantify mRNA expression at the
different sample locations at each developmental age. To quantify
mRNA expression in the ganglion cell layer (GCL)/nerve fiber layer
(NFL) we calculated the mean optical density of mRNA labeling (arbi-
trary units) in eight sample areas (8.8 m/1600 pixel2) at each location.
The sample area approximated the dimensions of a GC body in peri-
natal retina. In images with a prominent NFL (e.g., TOD location), the
sample areas were equally divided between the GCL and NFL. Within
each sample area, the mean gray value (pixel intensity on the 256-gray
shade scale) was measured (Measure function; ImageJ). Optical densi-
ties were calculated by normalizing the mean gray value measures
against the maximum pixel intensity in that sample location. Mean
pixel intensity  SD in the GCL/NFL was plotted against retinal loca-
tion for each age, and the levels of expression in all pair combinations
were compared by Kruskal-Wallis test and post hoc Dunn multiple
comparison test (P  0.01).
RESULTS
Quantitative Real-Time PCR
We detected all genes of interest in each of the biopsy regions
of human retina by RT-PCR (Fig. 1A). The differential expres-
sion of these genes in the macula relative to the surround and
nasal regions by QRT-PCR is illustrated in Figures 1B and 1C,
respectively, showing good agreement with data obtained
from our previous microarray analysis15 (asterisks indicate sig-
nificance at P 0.01). Comparison of data in Figures 1B and 1C
indicates that expression levels of these genes were similar in
the surround and nasal biopsies. The QRT-PCR findings con-
firm upregulation of both BNP and PEDF in the macula, com-
FIGURE 1. QRT-PCR amplification and measurement of differential gene expression. (A) Gel electrophoresis of QRT-PCR products amplified from
19 WG retinal RNA. Each gene was specifically amplified. Left, middle, right lanes of each gene triplet correspond to the surround (S), nasal (N),
and macular (M) retinal regions, respectively, from which RNA was extracted. (B, C) Differential gene expression in 19 WG retina shown as
percentage change SE. ( ) Change according to QRT-PCR; (u) changes according to microarray. The microarray shows a significant upregulation
of both BNP and PEDF in the macula, compared with the surround (B, *P  0.01 ANOVA), confirmed by QRT-PCR. Differences in levels of
expression of COL4A2 and NPRC, between macula and surround, are verified by QRT-PCR although the differences did not reach statistical
significance on the microarray. Similar patterns of differential regulation are detected when macular is compared with nasal samples, but also show
statistically significant downregulation of COL4A2 for both probe sets (C, *P  0.01 ANOVA). Note that the microarray includes more than one
probe set for COL4A2, NPRA, and NPRC, which interrogate different transcript sequences. NPRA was not differentially regulated in the macula
versus surround or macula versus nasal comparisons.
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pared with that in the surround (Fig. 1B) and nasal (Fig. 1C)
samples at 19 WG. In addition, the data indicate upregulation of
NPRC in the macula, but no differential expression of NPRA,
consistent with findings from the microarray. COL4A2 is the only
gene of the group that showed marked downregulation by QRT-
PCR, which in the microarray data were significant when com-
pared with expression in the nasal region (Fig. 1C, asterisk).
Expression of Pigment Epithelium–Derived
Factor (PEDF)
By ISH, we found higher levels of PEDF expression in the GCL
and in the RPE at the foveal locations, compared with periph-
ery, at all ages (Fig. 2). At Fd 80, mRNA expression was intense
in GCs at the incipient fovea (Fig. 2C), and detected at lower
levels in GCs at peripheral locations (Fig. 2D). This pattern,
showing high PEDF expression in foveal GCs and lower levels
of expression in GCs at peripheral locations, was also detected
at Fd 110 (Figs. 2E, 2F), Fd 145 (Figs. 2G, 2H), Fd 150 (Figs. 2J,
2K), Fd 164 (Figs. 2M, 2N), and P 5d (Figs. 2O, 2P). We also
detected higher levels of expression of PEDF in the RPE at the
fovea compared with peripheral locations, from Fd 55 (Figs.
2A, 2B) through P 3m (Figs. 2Q, 2R). The sense riboprobe
showed no specific labeling (Fig. 2L).
Brain Natriuretic Peptide (BNP) and Receptors
BNP mRNA Expression and Immunohistochemistry.
BNP mRNA was detected by ISH in the NFL, GCL, and inner
nuclear layer (INL), of fetal and postnatal macaque retinas (Fig. 3).
The most intense expression of BNP was in GCs of the central
macula, although neurons in the inner and outer regions of the
INL also expressed BNP. Co-localization of BNP mRNA with
anti-GFAP/-vimentin in end-foot-like structures at the retinal
surface (Figs. 3A–C, arrowheads) and in radial processes in the
INL and inner plexiform layer (IPL; Figs. 3E–G, arrows) indi-
cates that BNP mRNA is expressed in Mu¨ller cells. Co-localiza-
tion of BNP mRNA with vimentin-/GFAP-IR in the somas of
stellate cells deep in the GC layer, indicates that BNP is also
expressed in the somas of the retinal astrocytes that accom-
pany the developing perifoveal vessels (Figs. 3A–C, oblique
arrows). However, BNP mRNA was absent from the astrocyte
processes (Figs. 3A–C, vertical arrows). Similar patterns of BNP
expression were seen in the foveal regions of an additional six
animals aged between Fd 55 and 11 yo. The sense riboprobe
produced no specific labeling (Fig. 3D). Optical densitometry
FIGURE 2. ISH for PEDF showed an upregulation of expression in the
RPE and GCL of the central retina, near the site of incipient fovea
development (A, C, E, G, J, M, O, Q), relative to a more peripheral
location nasal to the optic nerve (B, D, F, H, K, L, N, P, R) in fetal and
perinatal macaque retina. The images have been converted to gray
scale and inverted so that the color reaction appears dark. (A, B) At Fd
55, PEDF expression was high in the RPE of central retina (A) and
reduced in retina near the optic nerve (B). (C, D) By Fd 80, a similar
high-to-low expression pattern was observed in the GCL between
central retina (C) and retina adjacent to the optic nerve (D). (E–P) An
upregulation of PEDF in the GCL and RPE was maintained in central
retina at Fd 110 (E), Fd 145 (G), Fd 150 (J), Fd 164 (M), and P 5d (O),
whereas a relative downregulation was observed eccentrically at each
of these respective ages (F, H, K, N, P). In tissue adjacent to the optic
nerve the sense riboprobe produced no specific labeling shown by the
lack of color reaction in the RPE at Fd 150 (L). The equivalent retinal
location in tissue hybridized to the antisense riboprobe showed posi-
tive RPE labeling (K). (Q–R) Greater PEDF expression in RPE in central
retina (Q) compared with peripheral retina (R) was observed up to P
3m. Note that the photoreceptor inner segments, which normally
show low-grade autofluorescence, are adjacent to the RPE in (R) but
have been displaced from the RPE in (Q). (C), (D), (J), and (K) are
reprinted from Peter Kozulin, Riccardo Natoli, Keely M. Bumsted
O’Brien, Michele C. Madigan, Jan M. Provis. Differential expression of
anti-angiogenic factors and guidance genes in the developing macula.
Mol Vis 2009;15:45–59). IS, inner segment; ONL, outer nuclear layer;
OPL, outer plexiform layer. Scale bar: (M–N) 50 m; (all other) 25 m.
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(Fig. 3H) indicates that, by Fd 55, levels of BNP are higher
temporally compared with nasal retina and that a clear peak of
BNP expression, which is maintained into adulthood, emerges
at the developing fovea by Fd 80.
Double labeling using antibodies to BNP and CRALBP (Fig. 4A)
showed mild BNP-immunoreactivity (IR) (green) in the inner part
of the INL (asterisk), diffuse labeling in the GCL (Fig. 4C), and
more intense labeling in association with vessel profiles in the INL
and GCL (Figs. 4A–C, arrows). Some CRALBP-immunoreactive
Mu¨ller cell processes in the INL were mildly immunoreactive to
BNP (Fig. 4A, arrowheads). BNP-IR was also present in RPE cells
(not shown). Double labeling with anti-vimentin suggests incon-
sistent co-localization in the glia limitans surrounding the retinal
vessels (Fig. 4B, arrow). Similarly, double labeling with anti-CD31
suggests inconsistent co-localization in vascular endothelial cells
(Fig. 4C, arrows). Overall, BNP-IR appeared to be within and/or
surrounding the vessels (Fig. 4C), rather than localized within
specific cellular structures, suggesting that the protein is distrib-
uted extracellularly.
Natriuretic Peptide Receptors A and C.We were unable to
detect specific labeling for NPRC mRNA by ISH and did not
detect immunoreactivity for NPRC protein in our series of
retinal sections. However, we detected strong NPRA-IR on
cones, vascular endothelial cells and GC axons (Figs. 4D, 4F–O,
4Q–R), and at lower levels in presumed bipolar cells in the INL
(not shown). NPRA-IR was detected in the cytoplasm of differ-
entiating cones in the foveal region at Fd 55 (Fig. 4D) and
between Fd 80, and adulthood NPRA-IR was prominent on the
membranes of cone axons (Figs. 4H, 4L, 4O, arrows). In vas-
cular endothelial cells, NPRA-IR was confirmed by co-localiza-
tion with CD31-IR at all ages (Figs. 4F, 4J, 4M, 4Q). NPRA-IR
was present on GC axons in fetal retinas (Figs. 4G, 4K, 4N,
arrowheads), but was absent in adult retina (Fig. 4R). Rabbit
IgG controls for anti-NPRA showed no specific labeling at all
ages tested (Figs. 4E, 4P).
Collagen type IV2 (COL4A2) Immunohistochemis-
try. We detected COL4A2-IR in mature retinal vessels in the
GCL, IPL, and INL of postnatal macaque retinas (Figs. 5A,
5B) and in well-differentiated retinal vessels in a whole-
mount fetal human retina at 21 WG (Figs. 5C, 5D).
COL4A2-IR was not detected in the fine, newly formed
endothelial cell networks of the 21-WG human retina. Dou-
FIGURE 3. BNP ISH in fetal macaque
retina (Texas Red color reaction).
(A–C) Strong BNP mRNA expression
was detected in ganglion cell bodies
(A). The color reaction colocalized
with vimentin-/GFAP-IR (green) in
the innermost portion of the NFL,
suggesting that mRNA is present
within Mu¨ller cell endfeet (arrow-
heads) at Fd 120. BNP was also ex-
pressed in the somas of astrocytes in
the outer portion of the GCL
(oblique arrows), and to a lesser de-
gree, in astrocyte horizontal pro-
cesses in the GCL and NFL (vertical
arrows). (D) The sense riboprobe
showed no specific labeling. (E–G)
High-magnification scans of the IPL
showing colocalization of BNP
mRNA and vimentin-/GFAP-IR in Mu¨l-
ler cell radial processes. (H) Quanti-
fication of BNP expression in GCL of
macaque retina using optical densi-
tometry analysis. Positive color reac-
tion appears dark. Histograms show
the mean (SD) optical density of
mRNA in the GCL/NFL at each of the
six retinal locations scanned (J). At
Fd 55, the mean optical density was
similar across each retinal location,
except in nasal retina where it is re-
duced. At Fd 80, BNP optical density
in the GCL was significantly greater
in fovea and temporal retina, and up-
regulation in the fovea was main-
tained until 11 yo. *P  0.01; **P 
0.001. ONL, outer nuclear layer.
Scale bars, 15 m.
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ble labeling with anti-CD31 to specifically localize the
COL4A2 protein on retinal vessels was not possible, because
both antibodies are raised in mouse.
DISCUSSION
The factors that define and maintain avascularity of the foveal
region of the primate retina have not been identified. In our
study, the results showed for the first time that the antiangio-
genic factor PEDF is highly expressed in the GCL of the incip-
ient fovea during development and that peak levels of expres-
sion of PEDF are maintained in the foveal region into adulthood
in the macaque retina. We also find higher levels of BNP in the
GCL of the foveal region of developing and adult macaque
retina. Because the retinal vessels initially form in the GCL and
the foveal avascular region is defined in this layer, expression
of these factors at high levels in the GCL at the developing
fovea during the initial phase of development of the perifoveal
capillaries, places them in the optimal location to regulate
retinal vascular growth.
Pigment Epithelium–Derived Factor
This is the first study to show a gradient of PEDF mRNA
expression in the GCL centered on the developing fovea. PEDF
is a serpin20 with neurotrophic and antiangiogenic func-
tions21–24 that are mediated through several pathways.23,25,26
PEDF-IR has been reported in the GC layer of fetal27 and
postnatal28 primate retina and in mouse retina.29 Localized
expression of PEDF in the GC layer at the developing fovea at
Fd 80, as described herein, coincides with the early phase of
FIGURE 4. BNP and NPRA immuno-
histochemistry (green) in macaque
retina. (A–C) BNP-IR (green) is asso-
ciated with developing vasculature.
Inconsistent BNP-IR was detected
around retinal vessels in INL, IPL, and
GCL of Fd 145 retina (arrows) and
was prominent around the inner part
of the INL (A, ✱). (A, arrowheads)
Low-grade BNP-IR in Mu¨ller cell pro-
cesses in the INL co-labeled with
anti-CRALBP (red). Co-localization
with vimentin-IR (red) indicates BNP
is possibly present within the glia
limitans (B, arrow). Double labeling
with anti-CD31 (red) shows BNP-IR
within and/or surrounding retinal
vessels (C, arrows), but no co-local-
ization in Fd 145 retina. (D–R) NPRA
immunohistochemistry (green) shown
with a range of counterlabels (red) in
macaque retina at different stages of
development (Fd 55, D–G; Fd 80,
H–K; Fd 145, L–N; 11 yo,O–R). Green
channel indicates NPRA-IR unless
specified otherwise. (D–G) At Fd 55,
NPRA-IR was present in the cytoplasm
of cones in central retina (D), and re-
mained upregulated in cone axons un-
til 11 yo (H, L, O, arrows). Rhodop-
sin-IR (red) was present in the outer
segments of developing rod photore-
ceptors (H, L, O, arrowheads).
NPRA-IR co-localized with CD31-IR
(red) in vascular endothelial cells at all
ages tested (F, J, M, Q). NPRA-IR was
also present in GC axon bundles in the
NFL in fetal retina (G, K, N, arrow-
heads). The GC axon bundles were
surrounded by vimentin-/GFAP-posi-
tive macroglial processes (red). In
adult retina, only very low levels of NPRA-IR were detected in GC axons (R). Rabbit IgG control serum for NPRA (green) showed no specific labeling
in fetal (E) or adult (P) retina. ONL, outer nuclear layer; OPL, outer plexiform layer; Rhod, rhodopsin; Vim, vimentin. Scale bars: (A–C) 25 m;
(D–R) 15 m.
FIGURE 5. COL4A2-IR (green) was observed predominantly on ma-
ture retinal vessels, particularly in peripheral retina. At P 5d COL4A2-IR
was present in peripheral retinal vessels in nasal (A) and temporal (B)
retina. The smaller COL4A2-positive vessels permeated the retina as
deep as the outer portion of the INL. (C, D) On 21-WG wholemount
retina, COL4A2-IR was detected in mature, well-differentiated vessels
in peripheral retina surrounding the macula. ONL, outer nuclear layer;
OPL, outer plexiform layer. Scale bar: (A, B) 50 m; (C, D) 100 m.
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growth of the vessels into the retina on the temporal side of the
optic disc.2–4 Paradoxically, at this early stage of development,
proangiogenic VEGF is also detected at high levels in the
avascular GC layer of the developing fovea between Fd 80
and 110.30 The present findings suggest that high levels of
expression of antiangiogenic PEDF in the GC layer counteract
the effects of proangiogenic VEGF,30 to prevent retinal vessels
from growing into the foveal region, and define the foveal
avascular area.
A similar mechanism of balance in expression of these two
factors in the RPE has been proposed to prevent spontaneous
neovascularization of neural retina from the choroid31,32 and
overexpression of VEGF in the RPE results in neovasculariza-
tion of the outer retina.33 Localization of peak expression of
PEDF to the fovea into adulthood may explain why the foveal
region normally remains avascular throughout life.
In the outer retina, the PEDF gene product is secreted by
the RPE into the interphotoreceptor matrix in vivo where it is
thought to have a role in maintenance of the avascular envi-
ronment of the outer retina.34,35 Consistent with those find-
ings, we detected PEDF expression in the RPE of developing
macaque retina, with higher levels of PEDF detected in the
more central RPE at early stages of development (Fig. 2).
During development, the photoreceptors in the central region
are more highly differentiated than in more peripheral loca-
tions. The higher levels of PEDF expression detected by ISH
may reflect a more advanced state of differentiation of the RPE
centrally in fetal retinas. Because the photoreceptor outer
segments (OS) and RPE become increasingly autofluorescent
with age, it was not possible to further analyze differential
expression of PEDF in the RPE in the postnatal period and into
adulthood, by using this approach.
Brain Natriuretic Peptide
BNP is one of a family of natriuretic peptides produced by the
heart and blood vessels that is well known for its role in the
regulation of blood pressure.36,37 These peptides are cleaved
by proteases, and the mature proteins act as hormones that
bind natriuretic peptide receptors to regulate sodium and wa-
ter homeostasis.38–40 There is a growing body of evidence
indicating that natriuretic peptides and their receptors have
even broader functional roles, in that they are expressed dy-
namically in different regions of the nervous system during
development,41,42 can directly regulate axon branching, out-
growth, and guidance42 and modulate GABAA-receptor activity.
43 In
addition, atrial natriuretic peptide (ANP) and type-C natriuretic
peptide (CNP) have inhibitory effects on VEGF,44,45 whereas
BNP is sensitive to hypoxia, the primary angiogenic stimulus,
via HIF-1.46 Relatively little detailed information is available,
however, concerning the signaling pathways involved. Of the
three natriuretic peptide receptors, BNP selectively interacts
with NPRA and NPRC.
Rollin et al.47 reported BNP-IR mainly in the inner layers of
adult human retina, including GCL cytoplasm, and in RPE cells.
We found that BNP-IR in macaque retina was similar to that in
human retinas, although we did not detect intense BNP-IR in
GCs, and Rollin et al.47 did not report immunoreactivity in the
vicinity of retinal blood vessels. These minor differences are
most likely due to tissue processing. BNP-IR has also been
reported in Mu¨ller48 and amacrine cells49 of rat retina. By ISH,
we found that BNP mRNA in macaque retinas was expressed
predominantly by GCs, as well as astrocytes and Mu¨ller cells,
from as early as Fd 55. Because BNP-IR was not strong in GC or
astrocytes in macaque retinas, but was predominantly in Mu¨ller
cells and in association with retinal vessels, our findings con-
firm that the BNP gene product is secreted in the retina. The
observation of mRNA in the inner processes of Mu¨ller cells
suggests that BNP protein synthesis within these cells is local-
ized to these sites. This extrasomatic expression pattern is not
uncommon in retinal cells, having been previously reported for
GFAP mRNA in Mu¨ller cells50 and FGF2, FGFR1, and R4 mRNAs
in cone photoreceptor inner segments.18,51
We detected NPRA-IR associated with retinal vessels, GC
axons in fetal retina, and cone photoreceptor axons in fetal and
mature macaque retinas. Downmodulation of NPRA expres-
sion in GC axons postnatally is consistent with reports of
changes in the expression patterns of these proteins during
development52,53 and suggests that BNP may have a specific
role in the development of GC axons.42 We also found low to
moderate levels of NPRA-IR associated with bipolar cells in
monkey retinas. In the rat, bipolar cells are immunoreactive to
both NPRA and NPRB, where it has been shown that BNP
modulates activity of rod bipolar cells through the NPRA re-
ceptor, leading to suppression of GABAA receptor–mediated
currents.43 Our findings suggest a similar role for BNP and
NPRA in the modulation of bipolar cell activity in macaque
retina.
Immunohistochemistry shows evidence of interaction be-
tween BNP and NPRA at the vascular interface, since localiza-
tion of both proteins is associated with retinal vessels. Local-
ization at the vascular interface supports the notion of an
antiangiogenic role for BNP, but may also indicate a role in
natriuresis and water homeostasis in the retina. Because cell
densities are higher in the macular region and correct extra-
cellular ionic composition is fundamental to neuronal function,
the higher levels of expression of BNP in the GCL of the foveal
region, in development and in adulthood, may reflect the need
for higher levels of natriuretic activity throughout life. Further
detailed studies are needed to clarify the specific functional
roles of BNP in the retina.
Collagen Type IV2
Type IV collagen is a prominent structural component of blood
vessel basement membranes54 and is a component of the
basement membrane of retinal vessels in mice.55,56 The anti-
angiogenic effects occur via the 2 chains, which contain the
24-kDa domain canstatin that inhibits angiogenesis via integrin-
mediated, apoptotic pathways. The present findings show that
collagen IV2 is localized to the basement membranes of
established retinal vessels; it was not detected in the network
of small vessels forming just outside the macula at 21 WG.
Thus, the low levels of COL4A2 transcripts detected in the
macula are due to the relative absence of retinal vessels in the
macula at 19 WG.
Retinal Vascular Development in Primates:
An Update
VEGF is the major angiogenic factor in the eye, and many
studies have shown that VEGF expression, mediated by a
relative hypoxia that is sensed by retinal astrocytes, is the
predominant factor promoting the formation of the retinal
vessels in development5,57–60 and disease.61,62 Extant models
of retinal vascular development, based on animal models in
which the macula is not present, have failed to explain satis-
factorily why retinal vessels are slow to grow into the macula63
and why the foveal region, in most cases, remains avascular.4,5
Indeed, we have shown previously that VEGF is highly ex-
pressed by GCs in the developing macula,30 and yet retinal
astrocytes and endothelial cell migration into the developing
macula is inhibited.
Our recent findings suggest that migration of astrocytes
from the optic nerve head into the temporal retina may be
inhibited because those astrocytes express the cell surface
proteins ephrin A1 and A4, and their receptor EphA6—with
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which they have an inhibitory interaction—is highly expressed
in temporal retina, and is at maximum levels in the developing
fovea.17 In the present study, we found peak expression of
PEDF in the GCL in the developing fovea that is present early
in development. Both the timing of the expression of PEDF by
GCs and the localization of peak expression to the foveal
region suggest that PEDF is the major factor that defines the
primate foveal avascular area. A specific role for BNP in vascu-
lar patterning in the macula is yet to be determined.
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